Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staccato Alprazolam PK/Safety in Adolescents with Epilepsy
NCT04857307Phase 1Completed
- Sponsor
- UCB
- Start
- Apr 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of alprazolam in epilepsy, sponsored by UCB. Primary endpoints: Maximum plasma concentration, Area under the plasma concentration-time curve from zero to the last quantifiable concentration and 4 more. Started Apr 2021; status: completed.
02
Drugs
alprazolam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT04857307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04857307.